Skip to main content

Monogram Makes History with Fully Remote Simulated Robotic Surgery

--News Direct--

Monogram Orthopaedics Inc. is pleased to announce the successful completion of the first fully remote simulated robotic surgery in orthopedic history. On Tuesday, March 7th, 2023, at 2 PM Eastern, Douglas Unis, MD of the Icahn School of Medicine at Mount Sinai in New York City, successfully completed the world's first fully remote total knee arthroplasty (TKA) procedure on a cadaver, controlling the Austin-based robot from New York City in real-time via the systems user-operated foot pedal. The event was live telecast.

“This was an incredible achievement for orthopedic robotics and medicine,” said founder Dr. Unis. “Despite being over 1,700 miles away, the real-time system was highly responsive with minimal latency. The applications for a robust system with these capabilities are tremendous. No system on the market today is capable of doing what Monogram just demonstrated.”

With the help of state-of-the-art robotic technology, the navigated mBôs prototype has demonstrated the possibilities for the next generation of surgical robotics. A replay of the event is available here.

“Our mission is to advance the standard of care in surgical robotics and orthopedics, “ said Ben Sexson, CEO. “I think we demonstrated that today with this historical demo. The achievement is a testament to our team's remarkable dedication and commitment.”

Monogram recently announced it had initiated its final financing round as a private company before its planned listing on Nasdaq. Investors can purchase directly on the Company’s website. The company has applied to list its shares on Nasdaq. Once approved, Monogram will trade under the ticker symbol "MGRM." For more information on how to purchase shares, visit www.monogramorthopedics.com.

About Monogram Orthopaedics Inc.

Monogram Orthopaedics is a medical technology company commercializing robotics and implants for the orthopedic market. The Company is based in Austin, Texas.

Monogram Orthopedics is changing the way orthopedic surgery is done. Our system combines personalized knee implants with precision robotic surgical assistants, giving patients a better-fitting knee replacement with minimally invasive surgery. 100,000 knee replacements failing each year in a $19.4B market represents an enormous opportunity for us.

This release may include ‘’forward-looking statements.‘’ To the extent that the information presented in this presentation discusses financial projections, information, or expectations about Monogram Orthopedics Inc.’s business plans, results of operations, products or markets, or otherwise makes statements about future events, such statements are forward-looking. Such forward-looking statements can be identified by the use of words such as ‘’should,‘’ ‘’may,‘’ ‘’intends,‘’ ‘’anticipates,‘’ ‘’believes,‘’ ‘’estimates,‘’ ‘’projects,‘’ ‘’forecasts,‘’ ‘’expects,‘’ ‘’plans,‘’ and ‘’proposes.‘’Although Monogram Orthopedics Inc. believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” and elsewhere in the offering statement filed with the SEC. Forward-looking statements speak only as of the date of the document in which they are contained, and Monogram Orthopedics Inc. does not undertake any duty to update any forward-looking statements except as may be required by law.The offering will be made only by means of an offering circular. An offering statement on Form 1-A relating to these securities has been filed with the U.S. Securities and Exchange Commission and has become qualified. The securities offered by Monogram are highly speculative. Investing in shares of Monogram involves significant risks. The investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that such investment could be illiquid for an indefinite period of time. No public market currently exists for the securities, and if a public market develops following the offering, it may not continue.Monogram intends to list its securities on a national exchange and doing so entails significant ongoing corporate obligations including but not limited to disclosure, filing and notification requirements, as well compliance with applicable continued quantitative and qualitative listing standards. For additional information on Monogram, the offering and any other related topics, please review the Form 1-A offering circular that can be found at the following location EDGAR Entity Landing Page. Additional information concerning Risk Factors related to the offering, including those related to the business, government regulations, intellectual property and the offering in general, can be found in the risk factor section of the Form 1-A offering circular.

Contact Details

Monogram Orthopaedics

Loreana David

+1 512-790-5151

info@monogramorthopedics.com

View source version on newsdirect.com: https://newsdirect.com/news/monogram-makes-history-with-fully-remote-simulated-robotic-surgery-223966437

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.